1. Home
  2. KAVL vs EVOK Comparison

KAVL vs EVOK Comparison

Compare KAVL & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KAVL
  • EVOK
  • Stock Information
  • Founded
  • KAVL 1998
  • EVOK 2007
  • Country
  • KAVL United States
  • EVOK United States
  • Employees
  • KAVL 18
  • EVOK N/A
  • Industry
  • KAVL Medicinal Chemicals and Botanical Products
  • EVOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • KAVL Health Care
  • EVOK Health Care
  • Exchange
  • KAVL Nasdaq
  • EVOK Nasdaq
  • Market Cap
  • KAVL 11.0M
  • EVOK 7.4M
  • IPO Year
  • KAVL N/A
  • EVOK 2013
  • Fundamental
  • Price
  • KAVL $1.35
  • EVOK $4.85
  • Analyst Decision
  • KAVL
  • EVOK
  • Analyst Count
  • KAVL 0
  • EVOK 0
  • Target Price
  • KAVL N/A
  • EVOK N/A
  • AVG Volume (30 Days)
  • KAVL 1.2M
  • EVOK 10.1K
  • Earning Date
  • KAVL 03-24-2025
  • EVOK 03-13-2025
  • Dividend Yield
  • KAVL N/A
  • EVOK N/A
  • EPS Growth
  • KAVL N/A
  • EVOK N/A
  • EPS
  • KAVL N/A
  • EVOK N/A
  • Revenue
  • KAVL $10,108,906.00
  • EVOK $8,617,036.00
  • Revenue This Year
  • KAVL $652.90
  • EVOK $97.35
  • Revenue Next Year
  • KAVL N/A
  • EVOK $99.52
  • P/E Ratio
  • KAVL N/A
  • EVOK N/A
  • Revenue Growth
  • KAVL N/A
  • EVOK 100.35
  • 52 Week Low
  • KAVL $0.58
  • EVOK $3.54
  • 52 Week High
  • KAVL $9.69
  • EVOK $12.32
  • Technical
  • Relative Strength Index (RSI)
  • KAVL 60.47
  • EVOK 56.27
  • Support Level
  • KAVL $1.13
  • EVOK $4.62
  • Resistance Level
  • KAVL $1.45
  • EVOK $4.94
  • Average True Range (ATR)
  • KAVL 0.18
  • EVOK 0.30
  • MACD
  • KAVL 0.01
  • EVOK 0.06
  • Stochastic Oscillator
  • KAVL 75.73
  • EVOK 59.28

About KAVL Kaival Brands Innovations Group Inc.

Kaival Brands Innovations Group Inc is focused on growing and incubating innovative and profitable products. The company is engaged in the sale, marketing and distribution of electronic nicotine delivery system (ENDS) products and related components. Its primary product includes Bidi Stick. The BIDI Stick comes in a variety of flavor options for adult cigarette smokers.

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Share on Social Networks: